Report on FOP Drug Development Forum
Please click on Report to read about this 2014 event. Click on Drug Development Forum to get more information incuding the agenda and organizations that attended. Do you have questions about this...
View ArticleClementia Announces Natural History Study in FOP.
The IFOPA is pleased to share news that Clementia Pharmaceuticals announces Natural History Study in FOP. To download and read the entire announcement please click on Natural History Study in FOP.
View ArticleClementia Raises Additional Financing
The IFOPA is pleased to share news that Clementia Pharmaceuticals secured an additional $10 million from current investors to support development of the company's lead compound palovarotene for the...
View ArticleInterested in Participating in the Clementia Phase 2 Clinical Trial?
Study is ongoing18 subjects left to enroll If you have a flare-up, or would like more information call or email: Lisa Gardo, UPenn at 215-294-9112 or Lisa.Gardo@uphs.upenn.edu Helene Favre, UCSF at...
View ArticleClementia Pharmaceuticals Opens Clinical Trial Site in Europe
The IFOPA is pleased to share news that Clementia Pharmaceuticals has opened a Clinical Trial Site in Europe for Phase 2 Study of Palovarotene in Patients with Fibrodysplasia Ossificans Progressiva...
View ArticleTravel Assistance for Clementia Clinical Trial Participants – pointer #9
What forms of transportation/travel assistanceare available to patients interested in participating in the Clementia Phase 2 clinical trial? Posted January 21, 2015 Travel arrangements to the clinical...
View ArticlePhase 2 Clinical Trial Sites - pointer #10
How many clinical sites are participating in the Phase 2 clinical trial and how were they selected? Posted February 4, 2015 The Phase 2 clinical trial is being conducted at four clinical sites...
View ArticleClementia completes enrollment of first cohort in Phase 2 clinical trial!
Posted February 5, 2015 Clementia is pleased to announce the enrollment of the 8th patient in Cohort 1 of its Phase 2 clinical trial of palovarotene for the treatment of FOP! This important milestone...
View ArticleGood Progress on Clementia's Phase 2 Clinical Trial of Palovarotene
Posted April 2, 2015 The IFOPA is pleased to share news that Clementia Pharmaceuticals advances Phase 2 Clinical Trial of Palovarotene in patients with Fibrodysplasia Ossificans Progressiva (FOP) based...
View ArticleEnrolling in the Clementia Phase 2 Trial from Outside the US, France or UK -...
Posted April 10, 2015 Will a patient who does not live in the United States (US), France or the United Kingdom (UK) be able to enroll in Clementia Phase 2 Clinical Trial? Patients who live outside the...
View Article
More Pages to Explore .....